Skip to main content
Premium Trial:

Request an Annual Quote

Chromatide Wins $145K Grant to Develop Enzyme-Immobiliziation Tech

NEW YORK (GenomeWeb News) — Purification products maker Chromatide said today it has won a £70,000 ($145,000) NorthWest Regional Development Agency award to develop enzyme-immobilization technology.
 
The Cheshire, UK-based company said the technology will lower the cost of immobilizing enzymes, which could simplify drug-development and chemical-production processes.
 
Don Wellings, the company’s chief scientific officer, said the technology allows the company to “create very effective immobilized enzymes … which can be used to simplify the use of biotransformation processes in a range of industries.”

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.